Bellevue Life Sciences Acquisition Corp.

As of May 8, 2024, the trend is bullish with mixed strength indicators, showing caution due to bearish signals in moving averages and Bollinger Bands despite a mildly bullish weekly MACD and RSI.

Bellevue Life Sciences Acquisition Corp. is a micro-cap finance company with recent net sales of $1 million and a net loss of $11 million, resulting in a market cap of $29.69 million. It has a P/E ratio of NA due to losses and a dividend yield of 0.00%.

As of Jun 18, Bellevue Life Sciences Acquisition Corp. has a market capitalization of 29.69 million and reported net sales of 0.76 million with a net profit of -13.74 million over the last four quarters.